The Morrison Government is making $276.4 million available through twelve research funding opportunities to improve health outcomes for all Australians and address today’s global health concerns to continue our support for Australian medical research.
Health and medical research in Australia continues to drive innovation in the development of novel cures and treatments for a variety of ailments, as well as enhancing our understanding of human health and discovering innovative strategies to improve the health of all Australians.
These funding rounds will feature possibilities in chronic respiratory illnesses, Indigenous health, and chronic neurological disorder research to help with this.
Early- and mid-career researchers contribute to the vitality of Australia’s research economy by bringing new ideas, innovation, and creativity to institutions around the country.
The Morrison Government is investing $42.8 million in a new Early to Mid-Career Researchers Grant Opportunity, which will be available to Australia’s budding researchers and will encourage them to develop solutions to some of the country’s most pressing health issues.
Researchers that collaborate with consumers or have a strong consumer engagement may be eligible for a total of $10 million in funding under the Consumer Led Research Program Grant Opportunity in 2021.
This money goes to initiatives that assist health-care consumers by addressing research questions that are more relevant and responsive to community needs, as well as seeking consumer input to improve research quality.
Many of Australia’s groundbreaking health ventures will benefit from the $50 million BioMedTech Incubator Grant Opportunity in 2021.
The incubator model permits commercially focused initiatives to get incremental funding of up to $5 million as they go through development milestones.
Researchers from various sectors of medicine are encouraged to apply for funding through the enlarged $71.6 million 2021 Clinical Trials Activity Grant Opportunity, which now includes research on uncommon cancers, rare disorders, and unmet needs.
Clinical trial funding guarantees that Australian researchers have access to resources for practical trials and analysis, allowing them to move their findings from the laboratory to clinical applications where they may improve people’s lives.
